Literature DB >> 33909994

Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.

Bin Huang1, Qiang Guo2, Marie L Niedermeier3, Jingdong Cheng4, Tatjana Engler1, Melanie Maurer5, Alexander Pautsch5, Wolfgang Baumeister6, Florian Stengel7, Stefan Kochanek8, Rubén Fernández-Busnadiego9.   

Abstract

The abnormal amplification of a CAG repeat in the gene coding for huntingtin (HTT) leads to Huntington's disease (HD). At the protein level, this translates into the expansion of a polyglutamine (polyQ) stretch located at the HTT N terminus, which renders HTT aggregation prone by unknown mechanisms. Here we investigated the effects of polyQ expansion on HTT in a complex with its stabilizing interaction partner huntingtin-associated protein 40 (HAP40). Surprisingly, our comprehensive biophysical, crosslinking mass spectrometry and cryo-EM experiments revealed no major differences in the conformation of HTT-HAP40 complexes of various polyQ length, including 17QHTT-HAP40 (wild type), 46QHTT-HAP40 (typical polyQ length in HD patients), and 128QHTT-HAP40 (extreme polyQ length). Thus, HTT polyQ expansion does not alter the global conformation of HTT when associated with HAP40.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HAP40; Huntington's disease; crosslinking; cryo-EM; cryoelectron microscopy; huntingtin; huntingtin-associated protein 40; mass spectrometry; polyQ; polyglutamine expansion

Mesh:

Substances:

Year:  2021        PMID: 33909994     DOI: 10.1016/j.str.2021.04.003

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  3 in total

1.  Purification of full-length recombinant human huntingtin proteins with allelic series of polyglutamine lengths.

Authors:  Hyeongju Kim; Kyung-Gi Hyun; Alejandro Lloret; Ihn Sik Seong; Ji-Joon Song
Journal:  STAR Protoc       Date:  2021-10-16

Review 2.  Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease.

Authors:  Manuel Seefelder; Fabrice A C Klein; Bernhard Landwehrmeyer; Rubén Fernández-Busnadiego; Stefan Kochanek
Journal:  J Huntingtons Dis       Date:  2022

Review 3.  Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin.

Authors:  Annarita Fiorillo; Veronica Morea; Gianni Colotti; Andrea Ilari
Journal:  J Pers Med       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.